{"disease":{"id":"recurrent-cns-tumors","name":"recurrent cns tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07374692","title":"Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04908176","title":"A Drug-drug Interaction Study of Avapritinib and Midazolam","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Blueprint Medicines Corporation","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}